Literature DB >> 28511439

Light Chain Myeloma induced Severe Hypertriglyceridemia.

Shafeeque Rahman1, Prabhat Kumar2, Subodh Kumar Mahto2, Rajinder Singh Tonk3, Rajesh S Taneja3.   

Abstract

Hyperlipidemia is very common in general population and incidence has further increased in recent years. Evaluation of patient presenting with lipid disorders is essential to obtain a definite diagnosis to prevent complications, and apply the most appropriate treatment. An isolated elevation in triglyceride levels may be caused by a primary disorder of lipid metabolism like familial hypertriglyceridemia. It may also arise secondary to a number of conditions like diabetes mellitus, alcohol intake, hypothyroidism, drugs, infections and nephrotic syndrome. Herein, we describe a case of secondary hypertriglyceridemia leading to Nonalcoholic Steatohepatitis (NASH) in a young female which was attributed to Multiple Myeloma (MM). Significant reduction in triglyceride levels after starting anti-myeloma therapy established their relation. This is the first case of light chain myeloma causing severe secondary hypertriglyceridemia.

Entities:  

Keywords:  Hyperlipidemic myeloma; Lipoprotein lipase; Multiple myeloma; Nonalcoholic steatohepatitis

Year:  2017        PMID: 28511439      PMCID: PMC5427365          DOI: 10.7860/JCDR/2017/24476.9360

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

Review 1.  Hyperviscosity syndrome in plasma cell dyscrasias.

Authors:  Jayesh Mehta; Seema Singhal
Journal:  Semin Thromb Hemost       Date:  2003-10       Impact factor: 4.180

2.  Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.

Authors:  B G Nordestgaard; S Abildgaard; H H Wittrup; R Steffensen; G Jensen; A Tybjaerg-Hansen
Journal:  Circulation       Date:  1997-09-16       Impact factor: 29.690

3.  A new mechanism of exogenous hyperglyceridemia.

Authors:  C J Glueck; A P Kaplan; R I Levy; H Greten; H Gralnick; D S Fredrickson
Journal:  Ann Intern Med       Date:  1969-12       Impact factor: 25.391

4.  Autoimmune hyperlipidemia with inhibitory monoclonal antibodies against low density lipoprotein binding to fibroblasts in a case with multiple myeloma.

Authors:  S Nozaki; Y Ito; T Nakagawa; S Yamashita; J Sasaki; Y Matsuzawa
Journal:  Intern Med       Date:  1997-12       Impact factor: 1.271

5.  Immunoglobulin D multiple myeloma: presenting features, response to therapy, and survival in a series of 53 cases.

Authors:  J Bladé; J A Lust; R A Kyle
Journal:  J Clin Oncol       Date:  1994-11       Impact factor: 44.544

6.  Multiple myeloma: review of 869 cases.

Authors:  R A Kyle
Journal:  Mayo Clin Proc       Date:  1975-01       Impact factor: 7.616

Review 7.  Hyperlipidemic myeloma: review of 53 cases.

Authors:  Benjamin Misselwitz; Jeroen S Goede; Bernhard C Pestalozzi; Urs Schanz; Jörg D Seebach
Journal:  Ann Hematol       Date:  2009-11-17       Impact factor: 3.673

8.  Review of 1027 patients with newly diagnosed multiple myeloma.

Authors:  Robert A Kyle; Morie A Gertz; Thomas E Witzig; John A Lust; Martha Q Lacy; Angela Dispenzieri; Rafael Fonseca; S Vincent Rajkumar; Janice R Offord; Dirk R Larson; Matthew E Plevak; Terry M Therneau; Philip R Greipp
Journal:  Mayo Clin Proc       Date:  2003-01       Impact factor: 7.616

9.  Hyperlipidemia associated with multiple myeloma.

Authors:  K Fukudome; J Kato; T Ohashi; Y Yamamoto; T Eto
Journal:  Intern Med       Date:  1996-04       Impact factor: 1.271

10.  Hypertriglyceridemia and its pharmacologic treatment among US adults.

Authors:  Earl S Ford; Chaoyang Li; Guixiang Zhao; William S Pearson; Ali H Mokdad
Journal:  Arch Intern Med       Date:  2009-03-23
  10 in total
  2 in total

1.  Correlation between Glycated Hemoglobin and Triglyceride Level in Type 2 Diabetes Mellitus.

Authors:  Syeda Naqvi; Shabnam Naveed; Zeeshan Ali; Syed Masroor Ahmad; Raad Asadullah Khan; Honey Raj; Shoaib Shariff; Chintan Rupareliya; Fatima Zahra; Saba Khan
Journal:  Cureus       Date:  2017-06-13

Review 2.  The Lipoprotein Transport System in the Pathogenesis of Multiple Myeloma: Advances and Challenges.

Authors:  Vasileios Lazaris; Aikaterini Hatziri; Argiris Symeonidis; Kyriakos E Kypreos
Journal:  Front Oncol       Date:  2021-03-26       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.